QuantumScape Corp

For the period ended Jun 30, 2026. Filed Jul 24, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 24, 2026

QS$4.45-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

(In Thousands)

Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Three Months Ended June 30, 2026 · Shares · Amount · Capital · Deficit · Income · Equity
Balance as of March 31, 2026		615,113		$61		$5,004,352		$(3,894,363)			$(384)		$1,109,666
Exercise of stock options and employee stock purchase plan		476		—		2,993		—			—		2,993
Shares issued upon vesting of restricted stock units		3,520		1		213		—			—		214
Stock-based compensation		—		—		23,595		—			—		23,595
Capital contribution under collaboration agreement - related party		—		—		10,353		—			—		10,353
Net loss		—		—		—		(98,240)			—		(98,240)
Unrealized loss on marketable securities		—		—		—		—			(610)		(610)
Balance as of June 30, 2026		619,109		$62		$5,041,507		$(3,992,603)			$(994)		$1,047,972
Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Six Months Ended June 30, 2026	Shares		Amount		Capital	Deficit	Income		Equity
Balance as of December 31, 2025		607,630		$61		$4,961,832		$(3,793,564)			$644		$1,168,973
Exercise of stock options and employee stock purchase plan		760		—		3,607		—			—		3,607
Shares issued upon vesting of restricted stock units		10,719		1		16,741		—			—		16,742
Stock-based compensation		—		—		48,974		—			—		48,974
Capital contribution under collaboration agreement - related party		—		—		10,353		—			—		10,353
Net loss		—		—			(199,039)			—		(199,039)
Unrealized loss on marketable securities		—		—		—		—			(1,638)		(1,638)
Balance as of June 30, 2026		619,109		$62		$5,041,507		$(3,992,603)			$(994)		$1,047,972

Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Three Months Ended June 30, 2025	Shares	Amount	Capital	Deficit	Income	Equity
Balance as of March 31, 2025	558,902	$56	$4,581,379	$(3,472,937)	$100	$1,108,598
Exercise of stock options and employee stock purchase plan	1,878	—	4,477	—	—	4,477
Shares issued upon vesting of restricted stock units	4,536	—	113	—	—	113
Stock-based compensation	—	—	26,519	—	—	26,519
Net loss	—	—	—	(114,698)	—	(114,698)
Unrealized loss on marketable securities	—	—	—	—	(213)	(213)
Balance as of June 30, 2025	565,316	$56	$4,612,488	$(3,587,635)	$(113)	$1,024,796
Common Stock · AdditionalPaid-In · Accumulated · AccumulatedOtherComprehensive · TotalStockholders’
Six Months Ended June 30, 2025	Shares	Amount	Capital	Deficit	Income	Equity
Balance as of December 31, 2024	542,549	$54	$4,515,879	$(3,358,514)	$428	$1,157,847
Exercise of stock options and employee stock purchase plan	9,960	1	15,658	—	—	15,659
Shares issued upon vesting of restricted stock units	12,601	1	20,239	—	—	20,240
Shares issued under At-the-Market Offering, net of issuance costs	206	—	907	—	—	907
Stock-based compensation	—	—	59,805	—	—	59,805
Net loss	—	—	—	(229,121)	—	(229,121)
Unrealized loss on marketable securities	—	—	—	—	(541)	(541)
Balance as of June 30, 2025	565,316	$56	$4,612,488	$(3,587,635)	$(113)	$1,024,796

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.